EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling-Reference-Cited by-同舟云学术

EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling

Published:2018-10-25 Issue:11 Volume:10 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Linder Markus¹,Glitzner Elisabeth¹,Srivatsa Sriram¹,Bakiri Latifa²,Matsuoka Kazuhiko²,Shahrouzi Parastoo¹,Dumanic Monika³,Novoszel Philipp¹,Mohr Thomas¹,Langer Oliver³⁴⁵,Wanek Thomas⁵,Mitterhauser Markus³⁶,Wagner Erwin F²,Sibilia Maria¹^ORCID

Affiliation:

1. Department of Medicine I Comprehensive Cancer Center Institute of Cancer Research Medical University of Vienna Vienna Austria

2. Spanish National Cancer Research Center (CNIO) Madrid Spain

3. Division of Nuclear Medicine Department of Biomedical Imaging and Image‐Guided Therapy Medical University of Vienna Vienna Austria

4. Department of Clinical Pharmacology Medical University of Vienna Vienna Austria

5. Center for Health & Bioresources AIT Austrian Institute of Technology GmbH Seibersdorf Austria

6. LBI Applied Diagnostics Vienna Austria

Funder

Austrian Science Fund

H2020 European Research Council

Publisher

EMBO